Edesa Biotech (EDSA) Net Equity Issued and Repurchased (2013 - 2025)
Edesa Biotech's Net Equity Issued and Repurchased was $3.5 million in fiscal Q1 2026 (quarter ended Dec 31, 2025), up 458.1% from $626,760 a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Net Equity Issued and Repurchased (2013 - 2025) Analysis & Trends
On a trailing twelve-month basis, Edesa Biotech's Net Equity Issued and Repurchased was $10.59 million through Dec 31, 2025, up 917.2% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $7.72 million, up 958.1% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 12.1% (FY2020 to FY2025).
- In earlier fiscal years, Net Equity Issued and Repurchased was $729,387 in FY2024 (-83.2%), $4.35 million in FY2023 (-63.7%), $11.96 million in FY2022 (+620.9%) and $1.66 million in FY2021 (-62.0%).
- Quarterly Net Equity Issued and Repurchased has moved between -$1.29 million (fiscal Q2 2022) and $11.96 million (fiscal Q3 2022) over five years.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was fiscal Q1 2026 (growth of 458.1%); the worst was fiscal Q4 2022 (a decline of 99.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Edesa Biotech | 40.56 Mn | 40.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.50 Mn |
| Sep 30, 2025 | 220,501.00 |
| Mar 31, 2025 | 6.87 Mn |
| Dec 31, 2024 | 626,760.00 |
| Jun 30, 2024 | 138,421.00 |
| Mar 31, 2024 | 275,765.00 |
| Dec 31, 2023 | 315,201.00 |
| Sep 30, 2023 | 483,772.00 |
| Jun 30, 2023 | 833,749.00 |
| Dec 31, 2022 | 3.03 Mn |
| Sep 30, 2022 | 120.00 |
| Jun 30, 2022 | 11.96 Mn |
| Mar 31, 2022 | -1.29 Mn |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | 191,233.00 |
| Mar 31, 2021 | 441,008.00 |
| Dec 31, 2020 | 1.03 Mn |
| Mar 31, 2020 | 4.32 Mn |
| Dec 31, 2019 | 45,000.00 |
| Sep 30, 2016 | 4.91 Mn |
API Access
Edesa Biotech Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();